<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Neural-network-based load modeling and its use in voltage stability analysis
2
Neural-network-based maximum power point tracking methods for photovoltaic systems operating under fast changing environments
3
Neural-network-based maximum-power-point tracking of coupled-inductor interleaved-boost-converter-supplied PV system using fuzzy controller
4
Neural-network-based model reference adaptive systems for high-performance motor drives and motion controls
5
Neural-network-based models for generating artificial earthquakes and response spectra
6
Neural-network-based motor rolling bearing fault diagnosis
7
Neural-Network-Based Numerical Control for Milling Machine
8
Neural-network-based optimal fuzzy controller design for nonlinear systems
9
Neural-network-based payload determination of a moving loader
10
Neural-network-based prediction of mooring forces in floating production storage and offloading systems
11
Neural-network-based regression model of ground surface settlement induced by deep excavation
12
Neural-network-based reliability analysis: a comparative study Original Research Article
13
Neural-network-based self-organized fuzzy logic control for arc welding
14
Neural-Network-Based Sensorless Maximum Wind Energy Capture With Compensated Power Coefficient
15
Neural-network-based water inflow forecasting
16
Neural-network-based waveform Processing and Delayless filtering in power electronics and AC drives
17
Neural-network-identification-based adaptive control of wing rock motions
18
Neural-networks for predicting the operation of an under-frequency load shedding system
19
NeuralNEURAL NETWORK CONTROL OF TWO 6 DOF ELECTRICALLY DRIVEN COOPERATING ROBOT MANIPULATORS CARRYING A RIGID OBJECT
20
Neural-optimal control algorithm for real-time regulation of in-line storage in combined sewer systems
21
Neural-Symbolic Learning and Reasoning Workshop at IJCAI-05, Edinburgh, Scotland
22
Neural-wavelet Methodology for Load Forecasting
23
Neural-Wiener-based Model Predictive Control (NWMPC) for Methyl Tert-butyl Ether Catalytic Distillation
24
Neuraminidase inhibitor and amantadine
25
Neuraminidase inhibitors for treatment of equine influenza – when all else fails?
26
Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study
27
Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities Original Research Article
28
Neuraminidase pharmacophore model derived from diverse classes of inhibitors
29
Neuraminidase produces dose-dependent decrease of slime production and adherence of slime-forming, coagulase-negative staphylococci
30
Neurasthenia: cross-cultural and conceptual issues in relation to chronic fatigue syndrome
31
Neuraxial block versus general anaesthesia for cesarean section: post-operative pain scores and analgesic requirements
32
Neuraxial Dexmedetomidine: Wonder Drug or Simply Harmful
33
Neurectomy for Treatment of Intercostal Neuralgia
34
Neuregulin 1 and Schizophrenia: Genetics, Gene Expression, and Neurobiology
35
Neuregulin 1-alpha expression in locally advanced breast cancer
36
Neuregulin 3 Genetic Variations and Susceptibility to Schizophrenia in a Chinese Population
37
Neuregulin 4 in Polycystic Ovarian Syndrome (PCOS) Phenotypes: A Key Role or Standby
38
Neuregulin activates erbB2-dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytes
39
Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation–contraction coupling and reduces oxidative stress in adult rat cardiomyocytes
40
Neuregulin-1 Gene and Schizophrenia, and its Negative Symptoms in an Iranian Population
41
Neuregulin-1 Induces Expression of Egr-1 and Activates Acetylcholine Receptor Transcription Through an Egr-1-binding Site
42
Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt
43
Neuregulin-1 reduces ischemia-induced brain damage in rats
44
Neuregulin-1/ErbB signaling is impaired in the rat model of diabetic cardiomyopathy
45
Neuregulin1/ErbB4 Signaling Induces Cardiomyocyte Proliferation and Repair of Heart Injury
46
Neuregulin-1/erbB-Activation Improves Cardiac Function and Survival in Models of Ischemic, Dilated, and Viral Cardiomyopathy Original Research Article
47
Neuregulin-1-Mediated Autocrine Signaling Underlies Sensitivity to HER2 Kinase Inhibitors in a Subset of Human Cancers
48
Neuregulins Response to Exercise: a Mini Review
49
NEURENTERIC CYST OF THE CRANIOVERTEBRAL JUNCTION
50
neurex: a tutorial expert system for the diagnosis of neurogenic diseases of the lower limbs
51
Neurilemmoma of the Parotid Gland
52
Neurite bridging across micropatterned grooves
53
Neurite extension of primary neurons on electrospun piezoelectric scaffolds
54
Neurite Extension: Starting at the Finish Line
55
Neurite guidance on protein micropatterns generated by a piezoelectric microdispenser
56
Neurite Outgrowth on Chromaffin Cells Applying Extremely Low Frequency Magnetic Fields by Permanent Magnets
57
Neurite outgrowth on well-characterized surfaces: preparation and characterization of chemically and spatially controlled fibronectin and RGD substrates with good bioactivity
58
Neurite outgrowth, survival and branching pattern of the postnatal myenteric plexus in vitro is influenced by ethanol
59
Neuritic plaques detected non-invasively
60
Neuritogenic cerebrosides from an edible chinese mushroom. Part 2: structures of two additional termitomycesphins and activity enhancement of an inactive cerebroside by hydroxylation Original Research Article
61
NEuro COgnitive REhabilitation for Disease of Addiction (NECOREDA) Program: From Development to Trial
62
Neuro Cognitive Tracking and Corrective Action: A Way Forward in Academic Performance
63
Neuro fuzzy based predict the insulation quality of high voltage rotating machine
64
Neuro fuzzy model for predicting the dynamic characteristics of beams
65
NEURO IMAGING OF CNS LESIONS IN AIDS
66
Neuro tissue engineering of glial nerve guides and the impact of different cell types
67
Neuroacanthocytosis in Two Brothers: An Ultra-rare Cause of Movement Disorder
68
Neuro-ACT Cognitive Architecture Applications in Modeling Driver’s Steering Behavior in Turns
69
Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers
70
Neuroactive steroids are not affected by panic induction with 50 μg cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers
71
Neuroactive Steroids in First-Episode Psychosis:A Role for Progesterone ?
72
Neuro-adaptive cooperative tracking control of unknown higher-order affine nonlinear systems
73
Neuro-adaptive hybrid controller for robot-manipulator tracking control
74
NEURO-ADAPTIVE VIBRATION CONTROL OF COMPOSITE BEAMS SUBJECT TO SUDDEN DELAMINATION
75
Neuroadrenergic activation and response to dobutamine in congestive heart failure secondary to idiopathic dilated cardiomyopathy
76
Neuroanatomic and Functional Correlates of Depressed Mood The Cardiovascular Health Study
77
Neuroanatomic contributions to slowed orienting of attention in children with autism
78
Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points
79
Neuroanatomic Map for Nerve Block Design in Breast Surgery
80
Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison
81
Neuroanatomical aging: Universal but not uniform
82
Neuroanatomical correlates of awareness of illness in patients with amnestic mild cognitive impairment who will or will not convert to Alzheimerʹs disease
83
Neuroanatomical correlates of familial language impairment: A preliminary report
84
Neuro-anatomical correlates of impaired retrieval of verbs and nouns: Interaction of grammatical class, imageability and actionality
85
Neuro-anatomical differences among epileptic and non-epileptic déjà-vu
86
Neuroanatomical discrimination between manipulating and maintaining processes involved in verbal working memory; a functional MRI study
87
Neuroanatomy and neurophysiology of the locust hypocerebral ganglion
88
Neuroanatomy in elbow arthroscopy
89
Neuroanatomy in Understanding Primate Brain Function: Status and Challenges
90
Neuroanatomy is Needed to Define the “Organs” of the Brain
91
Neuroanatomy of Alzheimerʹs disease: Hierarchical vulnerability and neural system compromise
92
Neuroanatomy of auditory verbal hallucinations in schizophrenia: A quantitative meta-analysis of voxel-based morphometry studies
93
Neuroanatomy of Cognition, Neuroanatomy and Cognition
94
Neuroanatomy of comorbid schizophrenia and learning disability: a controlled study
95
Neuroanatomy of impaired self-awareness in Alzheimerʹs disease and mild cognitive impairment
96
Neuroanatomy of the human affective system
97
Neuro-ANFIS Architecture for ECG Rhythm-Type Recognition Using Different QRS Geometrical-Based Features
98
Neuro-based formulation to predict fouling threshold in crude preheaters
99
Neurobehavior effects in four strains of mice offspring exposed prenatally to alprazolam
100
Neurobehavior in preterm neonates exposed to cocaine, alcohol, and tobacco
101
Neurobehavioral Alterations in Developing Transgenic Mice Expressing TNF-α in the Brain
102
Neurobehavioral and gestational effects of prenatal AZT exposure in Sprague-Dawley rats
103
Neurobehavioral and Neurophysiological Outcome of Chronic Low-Level Tetrachloroethene Exposure Measured in Neighborhoods of Dry Cleaning Shops
104
Neurobehavioral and Respiratory Findings in Jet Engine Repair Workers: A Comparison of Exposed and Unexposed Volunteers
105
Neurobehavioral and Social Sequelae of “Maajoune Illicit Drug” Use by Young Individuals
106
Neurobehavioral approach for evaluation of office workersʹ productivity: The effects of room temperature
107
Neurobehavioral assessment in forensic practice
108
Neurobehavioral Changes Among Workers in Some Chemical Industries in Egypt
109
Neurobehavioral Deficits in Persian Gulf Veterans: Additional Evidence from a Population-Based Study
110
Neurobehavioral Effects in Occupational Chemical Exposure Original Research Article
111
Neurobehavioral Effects of Chronic Occupational Exposure to Organic Solvents Among Japanese Industrial Painters
112
Neurobehavioral effects of exposure to trichloroethylene through a municipal water supply
113
Neurobehavioral Effects of Intrauterine Mercury Exposure: Potential Sources of Bias
114
Neurobehavioral Effects of Low-Level Methanol Vapor Exposure in Healthy Human Volunteers
115
Neurobehavioral Effects of Occupational Exposure to Low-Level Organic Solvents among Taiwanese Workers in Paint Factories, ,
116
Neurobehavioral Effects of Occupational Exposure to Organic Solvents Among Pharmaceutical Laboratory Workers in Iran
117
Neurobehavioral effects of power-frequency electromagnetic fields : N. Paneth, Environmental Health Perspectives Supplements, 101 (Suppl. 4)
118
Neurobehavioral Effects of Prolonged Exposure to Solid Air Freshener in Mice
119
Neurobehavioral Effects of Solvents: The Role of Alcohol
120
Neurobehavioral evaluation for a community with chronic exposure to hydrogen sulfide gas
121
Neurobehavioral frontal dysfunction in Alzheimerʹs disease with and without psychosis
122
Neurobehavioral Performance of Estate Residents with Privately-Treated Water Supply
123
Neuro-behavioral Profile and Toxicity of the Essential Oil of Dorema ammoniacum Gum as an Anti-seizure, Anti-Nociceptive, and Hypnotic Agent with Memory-enhancing Properties in D-Galactose Induced Aging Mice
124
Neurobehavioral sequelae of immunotherapy anaphylaxis
125
Neurobehavioral Symptoms and Family Functioning in Traumatically Brain-Injured Adults
126
Neurobehavioral tests are monitoring tools used to improve cardiac surgery outcome
127
Neurobehavioral Tests as a Medical Surveillance Procedure: Applying Evaluative Criteria
128
Neurobehavioral Toxicology in the 21st Century: A Future or a Failure? : The 1991 Hänninen Lecture
129
Neurobehavioural sequelae of cardiopulmonary b ypass
130
Neurobiochemical and clinical aspects of craving in alcohol addiction: A review
131
Neurobiochemical changes from Taxol/Neupogen chemotherapy for metastatic breast carcinoma corresponds with suicidal depression
132
Neurobiologic characteristics of umbilical artery lactate levels
133
Neurobiologic mechanisms of fetal heart rate response to vibroacoustic stimulation
134
Neurobiologic responses to speech in noise in children with learning problems: deficits and strategies for improvement
135
Neurobiological abnormalities in the relatives of schizophrenics
136
Neurobiological adaptations to violence across development
137
Neurobiological correlates of high (HAB) versus low anxiety-related behavior (LAB): differential Fos expression in HAB and LAB rats
138
Neurobiological Correlates of Social Conformity and Independence During Mental Rotation
139
Neurobiological mechanisms contributing to alcohol–stress–anxiety interactions
140
Neurobiological mechanisms of nicotine craving
141
Neurobiological mechanisms of relapse
142
Neurobiological parameters and anorexia nervosa: Findings from animal studies
143
Neurobiological perspectives on social phobia: from affiliation to zoology
144
Neurobiological studies of reading and reading disability
145
Neurobiological substrate of dimensions of schizophrenic illness
146
Neurobiological substrates of behavioral decline: Models and data analytic strategies for individual differences in aging
147
Neurobiologie des troubles dissociatifs
148
Neurobiology and neurochemistry of Rett syndrome
149
Neurobiology and neuropathology underlie the neuropsychological deficits associated with traumatic brain injury
150
Neurobiology in the Treatment of Eating Disorders: H.W. Hoek, J.L. Treasure and M.A. Katzman (Eds.): Wiley, Chichester, 1998, xi+529pp., £95.00.
151
Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression
152
Neurobiology of anxiety and fear: challenges for genomic science of the new millennium
153
Neurobiology of attention-deficit hyperactivity disorder
154
Neurobiology of atypical presentations among medicare beneficiaries with unstable angina pectoris
155
Neurobiology of cocaine binging in pregnancy
156
Neurobiology of Decision Making: A Selective Review from a Neurocognitive and Clinical Perspective
157
Neurobiology of decision-making: quo vadis?
158
Neurobiology of decreased heart rate variability in older patients with recent acute coronary syndrome
159
Neurobiology of depression and reduced heart rate variability in coronary artery disease
160
Neurobiology of emotion perception I: the neural basis of normal emotion perception
161
Neurobiology of emotion perception II: implications for major psychiatric disorders
162
Neurobiology of exaggerated heart rate oscillations during two meditative techniques
163
Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
164
Neurobiology of gender differences in reported symptoms for acute myocardial infarction
165
Neurobiology of HIV, psychiatric and substance abuse comorbidity research: Workshop report
166
Neurobiology of Nicotine Addiction: Implications for Smoking Cessation Treatment
167
Neurobiology of panic disorder
168
Neurobiology of prenatal influences on long-term psychomotor development in offspring of diabetic mothers
169
Neurobiology of prenatal maternal blood pressure response to stress
170
Neurobiology of psychosocial treatment of mental stress-induced myocardial ischemia in men
171
Neurobiology of Rett syndrome: a genetic disorder of synapse development
172
Neurobiology of Slow Coronary Flow
173
Neurobiology of speaking and stuttering
174
Neurobiology of Spinal Cord Injury, Edited by R.G. Kalb and S.M. Strittmatter, Humana Press, 1999, ISBN 0-896-03672-3. Hardcover: $125.00
175
Neurobiology of the obsessive–compulsive spectrum disorders
176
Neurobiology of Touretteʹs syndrome: concepts of neuroanatomic localization and neurochemical abnormalities
177
Neurobiology of U-Shaped Characteristic in Major Adverse Cardiac Events
178
Neurobiology of uterine irritability in preterm labor
179
Neuroblastoma
180
Neuroblastoma – a developmental perspective
181
Neuroblastoma – developmental and molecular biology meet therapy design
182
Neuroblastoma accompanied by hyperaldosteronism
183
Neuroblastoma Associated with Bilateral Ptosis: Report of a Rare Condition
184
Neuroblastoma Characteristics and Embryonic Origin of The Primary Lesion Site: A SEER Study
185
Neuroblastoma directed therapy by a rational prodrug design of etoposide as a substrate for tyrosine hydroxylase
186
Neuroblastoma in a patient with 47, XXX karyotype
187
Neuroblastoma in Adulthood
188
Neuroblastoma in an XYY male
189
Neuroblastoma in chromosomal breakage syndromes
190
Neuroblastoma in Early Age with Rare Respiratory Manifestation
191
Neuroblastoma in Europe: differences in the pattern of disease in the UK
192
Neuroblastoma in Two Siblings Supports the Role of 1p36 Deletion in Tumor Development
193
Neuroblastoma mass screening in children
194
Neuroblastoma oligo-capping cDNA project: toward the understanding of the genesis and biology of neuroblastoma
195
Neuroblastoma screening: investing in the right test
196
Neuroblastoma susceptibility genes in human FRAGILOME sequences
197
Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities
198
Neuroblastoma tumor cell-binding peptides identified through random peptide phage display
199
Neuroblastoma with MYCN amplification plus 11q deletion: immunohistochemical expression of angiogenic factors
200
Neuroblastoma: Therapeutic strategies for a clinical enigma
201
NEUROBLASTOMA;VARIABLE SYMPTOMS OF A NEUROGENIC TUMOR; A REPORT FROM IRAN
202
Neuroblastoma-like schwannoma in a case of schwannomatosis: Report of a rare case
203
Neuroblastoma-related severe hypoperfusion in the cerebellum of an infant: A case of opsoclonus-myoclonus syndrome
204
Neuroborreliosis
205
Neurobrucellosis and steroid therapy
206
Neurobrucellosis in a Patient With Multiple Sclerosis; A Case Report
207
Neurobrucellosis in Children, a Report of 2 Cases
208
Neurobrucellosis in systemic lupus erythematosus
209
Neurobrucellosis mimicking cerebral tumor: case report and literature review
210
Neurobrucellosis mimicking demyelinizating disorders
211
Neurobrucellosis Presented with a Hyperacute Onset: A Case Report
212
Neurobrucellosis Presented with a Hyperacute Onset: A Case Report
213
Neurobrucellosis Presenting with Unilateral Abducens Nerve Palsy
214
Neurobrucellosis: report of a rare disease in 20 Iranian patients referred to a tertiary hospital
215
Neurobrucellosis; A case report
216
Neurocardiogenic Mechanisms of Unexplained Syncope in Idiopathic Dilated Cardiomyopathy
217
Neurocardiogenic Syncope and Supraventricular Tachycardia in Association with a Rare Congenital Aortic Valve Abnormality
218
Neurochemical adaptation to cocaine abuse: reduction of N-acetyl aspartate in thalamus of human cocaine abusers
219
Neurochemical alterations in asymptomatic abstinent cocaine users: A proton magnetic resonance spectroscopy study
220
Neurochemical alterations of the entorhinal cortex in amnestic mild cognitive impairment (aMCI): A three-year follow-up study
221
Neurochemical analysis of amino acids, polyamines and carboxylic acids: GC–MS quantitation of tBDMS derivatives using ammonia positive chemical ionization
222
Neurochemical and behavioral effects of Cinnamomi cassiae (Lauraceae) bark aqueous extract in obese rats
223
Neurochemical and behavioral effects of green tea (Camellia sinensis): A model study
224
Neurochemical Approaches to Developing Biochemical Markers of Neurotoxicity: Review of Current Status and Evaluation of Future Prospects
225
Neurochemical bases of visceral nociception: Mathematical model
226
Neurochemical brain imaging investigations of schizophrenia
227
Neurochemical Changes in the Hippocampus of the Brown Norway Rat During Aging
228
Neurochemical diagnosis of Alzheimer’s dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau
229
Neuro-chemical Distortions among Patients with Leukaemia Receiving Chemotherapy
230
Neurochemical diversity of afferent neurons that transduce sensory signals from dog ventricular myocardium
231
Neurochemical Effects of Nicotine on Albino Rat’s Brain
232
Neurochemical effects of sleep deprivation in the hippocampus of the pilocarpine-induced rat model of epilepsy
233
Neurochemical imbalances linked to sleep disorders
234
Neurochemical Insights Into COVID-19-related Anosmia: A Commentary Study
235
Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains
236
Neurochemical mechanisms for cancer anorexia
237
Neurochemical Modulating Effect of Boswellia serrata Roxb. ex Colebr: A Preclinical Research
238
Neurochemical parameters of the main neurotransmission systems in aging mice
239
Neurochemical Profile of 8-Hydroxy-2-(Di-N-propylamino) tetralin (8-OH-DPAT) Induced Hyperphagia in Sugar Rich Diet Treated Rats
240
Neurochemical regulation of sleep
241
Neurochip logic design and simulation of an integrated classifier Original Research Article
242
Neurocinema: A brief overview
243
Neurocircuitry Models of Posttraumatic Stress Disorder and Extinction: Human Neuroimaging Research—Past, Present, and Future
244
Neurocircuitry of limbic dysfunction in anorexia nervosa
245
Neurocognition of auditory sentence comprehension: event related fMRI reveals sensitivity to syntactic violations and task demands
246
Neurocognitive alterations in first degree relatives of suicide completers
247
Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up
248
Neurocognitive and neuroimaging correlates of pediatric traumatic brain injury: A diffusion tensor imaging (DTI) study
249
Neurocognitive and symptomatic predictors of functional outcome in bipolar disorders: A prospective 1 year follow-up study
250
Neurocognitive changes after carotid revascularization: A review of the current literature
251
Neurocognitive changes in chronic liver disease
252
Neurocognitive changes in depressed patients in psychodynamic psychotherapy, therapy with fluoxetine and combination therapy
253
Neurocognitive characteristics of DUI recidivists
254
Neurocognitive Complications after Off-Pump and On-Pump CABG
255
Neurocognitive Complications after Ventricular Neuroendoscopy: A Systematic Review
256
Neurocognitive Correlates of Anxiety Disorders in Children:: A Preliminary Report
257
Neurocognitive correlates of CVLT performance in an academically impaired sample
258
Neurocognitive correlates of processing food-related stimuli in a Go/No-go paradigm
259
Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia
260
Neurocognitive correlates of white matter quality in adolescent substance users
261
Neurocognitive Decline After Off-Pump Versus On-Pump Coronary Artery Bypass
262
Neurocognitive deficit following coronary artery bypass grafting: a prospective study of surgical patients and nonsurgical controls
263
Neurocognitive deficits and psychiatric disorders in a NSW prison population
264
Neurocognitive Deficits in Individuals at Ultra-High-Risk for Psychosis: An Overview of Systematic Reviews
265
Neurocognitive development of children with congenital unilateral brain lesion and epilepsy
266
Neurocognitive disability, stroke, and surgery: A role for neuroergonomics
267
Neurocognitive dysfunction in antidepressant-free, non-elderly patients with unipolar depression: Alerting and covert orienting of visuospatial attention
268
Neurocognitive Dysfunction in Head Injured Patients, Does It Reveal Various Outcomes in Both Sexes and Age-Groups?
269
Neurocognitive effects after brief pulse and ultrabrief pulse unilateral electroconvulsive therapy for major depression: A review
270
Neurocognitive Effects In School Age Children Following Lead Exposure In Early Childhood
271
Neurocognitive effects of atypical and conventional antipsychotic drugs in schizophrenia: A naturalistic 6-month follow-up study
272
Neurocognitive Effects of Phenobarbital Discontinuation in children
273
Neurocognitive effects of phenobarbital discontinuation in epileptic children
274
Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression
275
Neurocognitive elements of antisocial behavior: Relevance of an orbitofrontal cortex account
276
Neurocognitive Function and Cerebral Emboli: Randomized Study of On-Pump Versus Off-Pump Coronary Artery Bypass Surgery
277
Neurocognitive function and quality of life in relation to hematocrit levels in chronic hemodialysis patients
278
Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects
279
Neurocognitive Function of Children suffering from Acute Lymphoblastic Leukemia in Southern Iran
280
Neurocognitive functioning and improvement in quality of life following participation in cardiac rehabilitation
281
Neurocognitive Functioning as a Predictor for Silent Infarction in Children with Sickle Cell Disease
282
Neurocognitive Functioning in AD/HD, Predominantly Inattentive and Combined Subtypes
283
Neurocognitive Functioning in Patients Undergoing Coronary Artery Bypass Graft Surgery or Percutaneous Coronary Intervention: Evidence of Impairment Before Intervention Compared With Normal Controls
284
Neurocognitive functioning in subjects with eating disorders: the influence of neuroactive steroids
285
Neurocognitive functioning in the prodrome of mania—an exploratory study
286
Neurocognitive functioning in young high-risk offspring having a parent with bipolar I disorder
287
Neurocognitive functions after aortic arch repair with right brachial artery perfusion
288
Neurocognitive functions and behavioral profiles in children with nephropathic cystinosis
289
Neurocognitive impairment after acute coronary syndrome: Prevalence and characterization in a hospital-based cardiac rehabilitation program sample
290
Neurocognitive impairment does not predict treatment outcome in obsessive–compulsive disorder
291
Neurocognitive impairment in adolescent major depressive disorder: State vs. trait illness markers
292
Neurocognitive impairment in middle-aged and older adults with bipolar disorder: Comparison to schizophrenia and normal comparison subjects
293
Neurocognitive inertia
294
Neurocognitive insights into substance abuse
295
Neurocognitive Manifestations of SARSCoV2: A Narrative Review of Mechanisms
296
Neurocognitive markers of psychosis in bipolar disorder: A meta-analytic study
297
Neurocognitive markers of psychosis in bipolar disorder: A meta-analytic study
298
Neurocognitive mechanisms of anxiety: an integrative account
299
Neurocognitive mechanisms of cognitive control: The role of prefrontal cortex in action selection, response inhibition, performance monitoring, and reward-based learning
300
Neurocognitive mechanisms underlying the experience of flow
301
Neurocognitive outcome after retrograde cerebral perfusion
302
Neurocognitive Outcomes 3 Years After Coronary Artery Bypass Graft Surgery: A Controlled Study
303
Neurocognitive outcomes following pediatric brain injury: A developmental approach
304
Neurocognitive Outcomes in Off-Pump Versus On-Pump Bypass Surgery: A Randomized Controlled Trial
305
Neurocognitive Outcomes of Off-Pump Versus On-Pump Coronary Artery Bypass: A Prospective Randomized Controlled Trial
306
Neurocognitive Performance in Children with ADHD and OCD
307
Neurocognitive performance using the Windows spaceflight cognitive assessment tool (WinSCAT) in human spaceflight simulations
308
Neurocognitive Profile in Adolescents with Early-Onset Schizophrenia: Clinical Correlates
309
Neurocognitive profile of children with Attention Deficit Hyperactivity Disorders (ADHD): A comparison between subtypes
310
Neurocognitive Profile of Children With Reading Disability in Kannada
311
Neurocognitive screening in Latinos: A comparison of the cross-cultural cognitive examination and the mini-mental state examination
312
Neurocomputational models of the remote effects of focal brain damage
313
Neurocomputing in Civil Infrastructure
314
Neurocontrol of a ball mill grinding circuit using evolutionary reinforcement learning
315
Neurocontrol of an aircraft: Application to windshear
316
Neuro-control of cable vibration using semi-active magneto-rheological dampers
317
Neuro-control of fixed offshore structures under earthquake
318
Neurocontrol of nonlinear systems via local memory neurons
319
Neurocontrol of Pressurized Water Reactors in Load-Follow Operations
320
Neurocontrol: A literature survey
321
Neurocontrol: Recent advances and links with the human brain
322
Neuro-controller design for nonlinear fighter aircraft maneuver using fully tuned RBF networks
323
Neuro-controller for reducing cyclic variation in lean combustion spark ignition engines
324
Neurocritical Care Unit Bed Allocation: Optimization Based on Prioritization Using Simulation
325
Neurocutaneous melanosis in an adult patient with diffuse leptomeningeal melanosis and a rapidly deteriorating course: Case report and review of the literature
326
Neurocutaneous syndromes: Behavioral features
327
Neurocycle Mind-management Approach: Effect on the Resiliency and Wellbeing of Female University Students
328
Neurocysticercosis - Islam and Other Religions
329
Neurocysticercosis and Oncogenesis
330
Neurocysticercosis immunodiagnosis using Taenia solium cysticerci crude soluble extract, excretory secretory and lower molecular mass antigens in serum and urine samples of Indian children
331
Neurocysticercosis in central Saudi Arabia
332
Neurocysticercosis in Europe: Still a public health concern not only for imported cases
333
Neurocysticercosis, mesial temporal lobe epilepsy, and hippocampal sclerosis: an association largely ignored
334
Neurocysticercosis: Changes after 25 Years of Medical Therapy
335
Neurocysticercosis: Changes After 25 Years of Medical Therapy
336
Neurocysticercosis: manifestations, diagnosis and treatment
337
Neurocysticercosis: manifestations, diagnosis and treatment
338
Neurocysticercosis: regional status, epidemiology, impact and control measures in the Americas
339
Neurocysticercosis: updated concepts about an old disease
340
Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome
341
Neurodegeneration as a mechanisms underlying ENS dysfunction: Translational concepts
342
Neurodegeneration in hereditary nucleotide repair disorders
343
Neurodegeneration with Brain Iron Accumulation: An Overview
344
Neurodegeneration, parkinsonian syndromes and autonomic failure
345
Neurodegeneration: a failure of neuroregeneration?
346
Neurodegeneration: new clues on inclusions Review Article
347
Neurodegenerations in domestic animals: a new way forward
348
Neurodegenerative aspects of protein aggregation
349
Neurodegenerative changes including altered tau phosphorylation and neurofilament immunoreactivity in mice transgenic for the serine/threonine kinase mos
350
NEURODEGENERATIVE DEMENTIA AND PARKINSONISM
351
Neurodegenerative diseases and oxidative stress
352
Neurodegenerative diseases and risk factors: A literature review
353
Neurodegenerative diseases in domestic animals: A comparative review
354
Neurodegenerative diseases: insights into pathogenic mechanisms from atherosclerosis
355
Neurodegenerative disorders, bullous pemphigoid and psoriasis: a comparative study in ethnic Poles indicates that Parkinson’s disease is more relevant to bullous pemphigoid
356
Neurodevelopment and the Transition from Schizophrenia Prodrome to Schizophrenia: Research Imperatives
357
Neurodevelopment of surviving infants at age two years, with a birthweight less than 2000 g and cared for in neonatal intensive care units (NICU)—results from a population based longitudinal study in Taiwan
358
Neurodevelopment outcomes and maternal methylmercury exposure: Breastfeeding is part of the solution not the problem
359
Neurodevelopment, Growth, and Viral Load in HIV-Infected Infants
360
Neurodevelopmental consequences of very preterm births
361
Neurodevelopmental course in pediatric onset progressive calcification of the basal ganglion: A case report
362
Neurodevelopmental damage after prenatal infection: Role of oxidative stress in the fetal brain
363
Neurodevelopmental differences in verbal fluency in children
364
Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study
365
Neurodevelopmental Disorders
366
Neurodevelopmental Disorders among Indian Children: Needs Attention
367
Neurodevelopmental effects of decabromodiphenyl ether (BDE-209) and implications for the Reference Dose
368
Neurodevelopmental Follow Up After Therapeutic Hypothermia for Perinatal Asphyxia
369
Neurodevelopmental integrity and zahavian bioacoustics
370
Neurodevelopmental Investigations among Methylmercury-Exposed Children in French Guiana
371
Neurodevelopmental outcome after laser therapy for twin-twin transfusion syndrome
372
Neurodevelopmental outcome at age two years amongst very low birth weight infants: results from a district general hospital
373
Neurodevelopmental outcome of congenital hypothyroidism in children between 1-5 years of age
374
Neurodevelopmental Outcome of Patients With Agenesis of Corpus Callosum
375
Neurodevelopmental outcome of premature infants after antenatal phenobarbital exposure
376
NEURODEVELOPMENTAL OUTCOME ONE YEAR AFTER EARLY VERSUS LATE SELECTIVE SURFACTANT TREATMENT
377
Neurodevelopmental outcome related to cerebral risk factors in children after neonatal arterial switch operation
378
Neurodevelopmental Outcomes of Infants with Benign Enlargement of the Subarachnoid Space
379
Neurodevelopmental outcomes of infants with birth weights of less than 1000 g: comparison between periods before and after the introduction of surfactant
380
Neurodevelopmental Outcomes of Seychellois Children from the Pilot Cohort at 108 Months Following Prenatal Exposure to Methylmercury from a Maternal Fish Diet,
381
Neurodevelopmental patterns of visual P3b in association with familial risk for alcohol dependence and childhood diagnosis
382
Neurodevelopmental Status in 3 - 5 Years-Old Children with a History of Congenital and Acquired Hypothyroidism
383
Neurodevelopmental Status of Infants Conceived Assisted Reproductive Techniques in Royan Institute
384
Neurodevelopmental Toxic Effects of Food Additives Used in Energy Drinks on Developing Rats
385
Neurodevelopmental toxicity of methylmercury: Laboratory animal data and their contribution to human risk assessment
386
Neurodevelopmental, immunological and endocrinological indices of perinatal human exposure to PCBs and dioxins
387
Neurodisruption of selective attention: insights and implications
388
Neuro-dynamic trading methods
389
Neurodynamical amplification of perceptual signals via system-size resonance
390
Neuroecology and psychological modularity
391
Neuroeconomics and the metastable brain
392
Neuroeconomics: cross-currents in research on decision-making
393
Neuroeconomics: Present and future
394
Neuroelectric and behavioral indices of interference control during acute cycling
395
Neuroelectric correlates of response production and inhibition in individuals at risk to develop alcoholism
396
Neuroelectrical signs of selective attention to color in boys with attention-deficit hyperactivity disorder
397
Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis?
398
Neuroendocrine activation in heart failure is modified by endurance exercise training
399
Neuroendocrine Adenoma of Middle Ear Causing Acute Onset Facial Palsy- A Rare Case Report
400
Neuroendocrine aging in birds: Comparing lifespan differences and conserved mechanisms
401
Neuroendocrine and behavioral interaction in exposure treatment of phobic avoidance
402
Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas
403
Neuroendocrine and Clinical Characteristics of Major Depressed Patients Exhibiting Sleep-Onset REM
404
Neuroendocrine aspects of chronic fatigue syndrome: a commentary
405
Neuro-endocrine biomarkers of pollution-induced stress in marine invertebrates q
406
Neuroendocrine biomarkers, allostatic load, and the challenge of measurement: A commentary on Gersten
407
Neuroendocrine biomarkers, social relations, and the cumulative costs of stress in Taiwan
408
Neuroendocrine Cancer of Rectum Metastasizing to Ovary
409
Neuroendocrine carcinoma (carcinoid) of the thymus associated with Cushing’s syndrome
410
Neuroendocrine carcinoma associated with X-linked hyper-immunoglobulin M syndrome: Report of four cases and review of the literature
411
NEUROENDOCRINE CARCINOMA OF OVARY IN ASSOCIATION WITH MUCINOUS CYSTADENOMA
412
Neuroendocrine carcinoma of the ovotestis: A case report and review of literatures
413
Neuroendocrine Carcinoma of the Stomach; A Case Report
414
Neuroendocrine carcinoma of unknown primary: A systematic review of the literature and a comparative study with other neuroendocrine tumors
415
Neuroendocrine Carcinomas of the Stomach: Computed Tomography and Pathologic Findings in 32 Patients
416
Neuroendocrine cells in the vestibular glands of the genital tract of cows and pigs
417
Neuroendocrine changes in systemic lupus erythematosus and Sjögrenʹs syndrome
418
Neuroendocrine Consequences of Prenatal Androgen Exposure in the Female Rat: Absence of Luteinizing Hormone Surges, Suppression of Progesterone Receptor Gene Expression, and Acceleration of the Gonadotropin-Releasing Hormone Pulse Generator
419
Neuroendocrine correlates of chronic fatigue syndrome: A brief review
420
Neuro-endocrine correlates of ovarian development and egg-laying behaviors in the primitively eusocial wasp (Polistes chinensis)
421
Neuroendocrine differentiated carcinomas of the breast: a distinct entity
422
Neuroendocrine disruption and health effects in Elliptio complanata mussels exposed to aeration lagoons for wastewater treatment Original Research Article
423
Neuroendocrine disruption in Mya arenaria clams during gametogenesis at sites under pollution stress
424
Neuroendocrine evidence for dopaminergic actions of hypericum extract (LI 160) in healthy volunteers
425
Neuroendocrine facets of human puberty
426
Neuroendocrine factors affecting the steady-state levels of early trypsin mRNA in Aedes aegypti
427
Neuroendocrine factors alter host defense by modulating immune function
428
Neuroendocrine hormones such as growth hormone and prolactin are integral members of the immunological cytokine network
429
Neuroendocrine immune mechanisms in rheumatic diseases
430
Neuroendocrine immune responses to inflammation: the concept of the neuroendocrine immune loop
431
Neuroendocrine Influences and Repercussions of the Menopause
432
Neuroendocrine insights from the laboratory to the clinic
433
Neuroendocrine interactions in the immune system
434
Neuroendocrine involvement in aging: Evidence from studies of reproductive aging and caloric restriction
435
Neuroendocrine involvement in the aging: Evidence from studies of reproductive aging and caloric restriction
436
Neuroendocrine mechanisms for immune system regulation during stress in fish
437
Neuroendocrine mechanisms in fibromyalgia–chronic fatigue
438
Neuroendocrine regulation of gonadotropins in the male and the female
439
Neuroendocrine regulation of rearing behavior in the native Thai hen
440
Neuroendocrine regulation of seasonal morph development in a bivoltine race (Daizo) of the silkmoth, Bombyx mori L.
441
Neuroendocrine response to antipsychotics: effects of drug type and gender
442
Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome
443
Neuroendocrine secretory protein 55 (NESP55) immunoreactivity in male and female rat superior cervical ganglion and other sympathetic ganglia
444
Neuroendocrine stress response and hyperglycemia in children undergoing laparoscopic surgery: a comparative study between remifentanil infusion and fentanyl boluses during sevoflurane-based anesthesia
445
Neuroendocrine Study of Serotonin Function in Female Borderline Personality Disorder Patients: A Pilot Study
446
Neuroendocrine Tumor of the Gallbladder
447
Neuroendocrine tumors (carcinoid) of the thymic gland
448
Neuroendocrine tumors and conotruncal cardiac defects
449
Neuroendocrine tumors of the lung and octreotide scintigraphy
450
Neuroendocrine tumors of the lung and octreotide scintigraphy: reply
451
Neuroendocrine tumors of the thymus: a clinicopathological and prognostic study
452
Neuroendocrine tumours (carcinoids) of the appendix
453
Neuroendocrine tumours in various organ systems in a ten-year period
454
Neuroendocrine tumours: clinical presentation and management of localized disease
455
Neuroendocrine vs. Paracrine Control of Follicle-Stimulating Hormone
456
Neuroendocrine, Cognitive and Structural Imaging Characteristics of Women on Longterm Sickleave with Job Stress–Induced Depression
457
Neuroendocrine, polysomnographic and psychometric observations in healthy subjects at high familial risk for affective disorders: the current state of the ‘Munich vulnerability study’
458
Neuroendocrine–immune interactions in fish: a role for interleukin-1
459
Neuroendocrine–immune interactions in fish: a role for interleukin-1
460
Neuroendocrine-Induced Synthesis of Bone Marrow-Derived Cytokines with Inflammatory Immunomodulating Properties
461
Neuroendocrine-mediated alteration of CD8+ T cell and microglia immune function during the development of stress-induced herpes simplex virus type-1 (HSV-1) encephalitis
462
Neuroepidemiology not only for neuroepidemiologists
463
Neuroepithelial Cells Supply an Initial Transient Wave of MSC Differentiation
464
Neuroepithelial Stem Cell Proliferation Requires LIS1 for Precise Spindle Orientation and Symmetric Division
465
Neuro-estimator based GMC control of a batch reactive distillation
466
Neuroet: An easy-to-use artificial neural network for ecological and biological modeling
467
Neuroet: An easy-to-use artificial neural network for ecological and biological modeling
468
Neuroethical Theories
469
Neuroethics, reductionism and dualism
470
Neuroethics: A Moral Approach Towards Neuroscience Research
471
Neuroethics: An emerging new discipline in the study of brain and cognition
472
Neuroethics: the practical and the philosophical
473
Neuroethics; Neuroscience for Ethics and/or Ethics for Neuroscience New Challenge for Third Millennium
474
Neuroethological study of status epilepticus induced by systemic pilocarpine in Wistar audiogenic rats (WAR strain)
475
Neuroethology application for the study of human temporal lobe epilepsy: From basic to applied sciences
476
Neuro-evolutionary approach applied for optimizing the PEMFC performance
477
Neuro-evolutionary optimization methodology applied to the synthesis process of ash based adsorbents
478
Neurofascial Dextrose Prolotherapy for Managing Chronic Ankle Ligament Injury
479
Neurofeedback and epilepsy
480
Neurofeedback Effect on Perceptual-Motor Skills of Children with ADHD
481
Neurofeedback provides a better theta-rical performance
482
Neurofeedback Training Versus Perceptual-motor Exercises Interventions in Visual Attention for Children With Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial
483
Neurofeedback treatment of pseudoseizure disorder
484
Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation
485
Neuroferritinopathy: A Window on the Role of Iron in Neurodegeneration
486
Neurofibrillary changes of the Alzheimer type in very elderly individuals: Neither inevitable nor benign: Commentary on “No disease in the brain of a 115-year-old woman”
487
Neurofibrillary degeneration and cell loss in the nucleus basalis in comparison to cortical Alzheimer pathology
488
Neurofibrillary pathology — correlation with hippocampal formation atrophy in Alzheimer disease
489
Neurofibrillary tangle-associated alteration of stathmin in Alzheimerʹs disease
490
Neurofibrillary tangles and plaques are not accompanied by white matter pathology in aged triple transgenic-Alzheimer disease mice
491
Neurofibroma of the breast in a boy with neurofibromatosis type 1
492
Neurofibroma of the Esophagus
493
Neurofibroma of the Sciatic Nerve with Neurofibromatosis Type 1
494
Neurofibroma with Bone Destruction Masquerading Extracranial Meningioma
495
Neurofibromas as bilateral cystic chest wall swellings
496
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective
497
Neurofibromatosis 1 presenting as a rare widespread neurofibromas with cord compression
498
Neurofibromatosis 2 gene in human colorectal cancer
499
Neurofibromatosis 2 Phenotypes and Germ-Line NF2 Mutations Determined by an RNA Mismatch Method and Loss of Heterozygosity Analysis in NF2 Schwannomas
500
Neurofibromatosis of the Esophagus
501
Neurofibromatosis Presenting as Painless Clitoromegaly
502
Neurofibromatosis type 1 and hyperparathyroidism. Case report
503
Neurofibromatosis Type 1 and Type 2: review of the central nervous system and related structures
504
Neurofibromatosis type 1 with pregnancy-associated renovascular hypertension and the syndrome of hemolysis, elevated liver enzymes, and low platelets, ,
505
Neurofibromatosis type I (von Recklinghausen’s disease): A family case report and literature review
506
Neurofibromatosis with Bilateral Renal Artery Stenosis and End Stage Renal Disease: Case Report
507
Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning
508
Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning
509
Neurofibrosarcoma of the duodenum
510
Neurofilament expression in the rat brain after cerebral infarction: effect of age
511
Neurofilament heavy chain gene polymorphism and risk of multiple sclerosis
512
Neurofilament light chain gene polymorphism and risk of multiple sclerosis in Iranian patients
513
Neurofilament M mRNA is Expressed in Conduction System Myocytes of the Developing and Adult Rabbit Heart,
514
Neuro-flow dynamics and the learning processes
515
Neurofolicullar hamartoma presenting as a rare adnexal neoplasm in association with basal cell carcinoma
516
Neurofunctional correlates of long-term arsenic exposure in humans
517
Neurofunctional correlates of personality traits in relapsing-remitting multiple sclerosis: An fMRI study
518
Neuro-fuzzy adaptive control based on dynamic inversion for robotic manipulators
519
NeuroFuzzy adaptive modelling and control : By Martin Brown and Chris Harris. Prentice-Hall, Englewood Cliffs, NJ (1994). IBSN 0-13-134453-6
520
Neuro-fuzzy and genetic algorithm in multiple response optimization
521
Neuro-fuzzy and neural network systems for air quality control
522
Neuro-fuzzy and neural network techniques for forecasting sea level in Darwin Harbor, Australia
523
Neuro-fuzzy approach for online message scheduling
524
Neuro-fuzzy approach for online message scheduling
525
Neuro-fuzzy approach to adaptive digital predistortion
526
Neurofuzzy approach to process parameter selection for friction surfacing applications
527
Neuro-fuzzy approach to processing inputs with missing values in pattern recognition problems Original Research Article
528
Neuro-fuzzy approach to real-time transient stability prediction based on synchronized phasor measurements
529
Neuro-fuzzy approach versus rough-set inspired methodology for intelligent decision support
530
Neuro-Fuzzy Approaches for Sanitary Sewer Pipeline Condition Assessment
531
Neuro-fuzzy ART-based document management system: application to mail distribution ، digital libraries
532
Neuro-Fuzzy Based Algorithm for Online Dynamic Voltage Stability Status Prediction Using Wide-Area Phasor Measurements
533
Neuro-fuzzy based constitutive modeling of undrained response of Leighton Buzzard Sand mixtures
534
Neuro-Fuzzy Based Performance Evaluation of Shunt Motor
535
Neuro-fuzzy based time-delay estimation using DCT coefficients
536
Neuro-fuzzy chip to handle complex tasks with analog performance
537
Neurofuzzy classification and rule generation of modes of radiowave propagation
538
Neuro-fuzzy closed-loop control of depth of anaesthesia
539
Neuro-fuzzy clustering of radiographic tibia image data using type 2 fuzzy sets
540
Neurofuzzy cognitive maps with adaptive B-splines
541
Neuro-fuzzy control for autonomous wind–diesel systems using biomass
542
Neurofuzzy control of a low-temperature desulphurization plant
543
Neuro-Fuzzy Control of a Robotic Exoskeleton With EMG Signals
544
Neuro-fuzzy control of bilateral teleoperation system using FPGA
545
Neurofuzzy control of modular and reconfigurable robots
546
Neuro-Fuzzy Control of Railcar Vibrations Using Semiactive Dampers
547
Neuro-fuzzy control of underwater vehicle-manipulator systems
548
Neuro-fuzzy controller for gas turbine in biomass-based electric power plant
549
Neurofuzzy design and model construction of nonlinear dynamical processes from data
550
Neuro-fuzzy dynamic model with Kalman filter to forecast irradiance and temperature for solar energy systems
551
Neuro-Fuzzy Estimation in Spatial Statistics
552
Neuro-Fuzzy Expert System for evaluating the performance of Distributed Software System Architecture
553
Neuro-fuzzy ID3: a method of inducing fuzzy decision trees with linear programming for maximizing entropy and an algebraic method for incremental learning
554
Neurofuzzy Inverse Jacobian Mapping for Multi-Finger Robot Hand Control
555
Neuro-fuzzy inverse model control structure of robotic manipulators utilized for physiotherapy applications
556
Neuro-fuzzy knowledge processing in intelligent learning environments for improved student diagnosis
557
Neuro-Fuzzy Logic Model for Evaluating Water Content of Sandy Soils
558
Neuro-fuzzy MIMO nonlinear control for ceramic roller kiln
559
Neuro-fuzzy mixture of experts network parallel learning and model construction algorithms
560
Neuro-fuzzy model of hybrid semi-active base isolation system with FPS bearings and an MR damper
561
Neuro-fuzzy Model-based Control
562
Neurofuzzy model-based predictive control of weld fusion zone geometry
563
Neuro-fuzzy modeling based genetic algorithms for identification of geochemical anomalies in mining geochemistry
564
Neuro-fuzzy modeling of rotation capacity of wide flange beams
565
Neuro-fuzzy modeling to adsorptive performance of magnetic chitosan nanocomposite
566
Neuro-fuzzy Modelling and Experimental Study of the Physiological Comfort of Green Cotton Fabric Based on Yarn Properties
567
Neuro-fuzzy modelling of power plant flue-gas emissions
568
Neuro-fuzzy network approach for modeling submicron MOSFETs: application to MOSFET subcircuit simulation
569
Neuro-fuzzy network for flavor recognition and classification
570
Neuro-fuzzy network for the classification of buried pipe defects
571
Neurofuzzy network model construction using Bezier-Bernstein polynomial functions
572
Neurofuzzy network modelling ، control of steam pressure in 300 MW steam-boiler system
573
Neuro-fuzzy networks ، their application to fault detection of dynamical systems
574
Neuro-fuzzy networks for voltage security monitoring based on synchronized phasor measurements
575
Neuro-fuzzy pattern classification for fault diagnosis in nuclear components
576
Neuro-fuzzy reasoning for occluded object recognition
577
Neuro-fuzzy relational systems for nonlinear approximation and prediction Original Research Article
578
Neuro-fuzzy river ice breakup forecasting system
579
Neuro-Fuzzy Sensor Fault Diagnosis of an Induction Motor
580
Neuro-fuzzy Sliding Mode Controller Based on a Brushless Doubly Fed Induction Generator
581
Neuro-fuzzy soft-switching hybrid filter for impulsive noisy environments
582
Neuro-fuzzy speed control of traveling-wave type ultrasonic motor drive using frequency and phase modulation
583
Neuro-fuzzy speed tracking control of traveling-wave ultrasonic motor drives using direct pulsewidth modulation
584
Neurofuzzy state identification using prefiltering
585
Neuro-fuzzy synergism to the intelligent system for edge detection and enhancement
586
Neuro-fuzzy system in partitioned client-side Web cache
587
Neuro-fuzzy system to predict permeability and porosity from well log data: A case study of Hassi R׳Mel gas field, Algeria
588
Neuro-fuzzy system with high-speed low-power analog blocks
589
Neuro-fuzzy system with learning tolerant to imprecision
590
Neuro-fuzzy systems for diagnosis
591
Neuro-fuzzy systems for function approximation
592
Neuro-fuzzy techniques for traffic control
593
Neuro-fuzzy TSK network for calibration of semiconductor sensor array for gas measurements
594
Neuro-fuzzy uncertainty de-coupling: a multiple-model paradigm for fault detection and isolation
595
Neuro-Fuzzy-Based Solar Cell Model
596
Neurofuzzy-model-following control of MIMO nonlinear systems
597
Neurogastroenterology: imaging of the sensory and motor control of the GI tract
598
Neurogenesis and depression: etiology or epiphenomenon?
599
Neurogenesis and Helplessness Are Mediated by Controllability in Males But Not in Females
600
Neurogenesis and neural stem cells in the dorsal vagal complex of adult rat brain: New vistas about autonomic regulations—a review
601
Neurogenesis in adulthood: a possible role in learning
602
Neurogenesis in gerbil hippocampus following brain ischemia: Focus on the involvement of metalloproteinases
603
Neurogenesis interferes with the retrieval of remote memories: Forgetting in neurocomputational terms
604
Neuro-genetic approach for optimisation of the spectrophotometric catalytic determination of cobalt
605
Neuro-genetic approach for optimisation of the spectrophotometric catalytic determination of cobalt Original Research Article
606
Neuro-genetic approach to multidimensional fuzzy reasoning for pattern classification
607
Neuro-genetic multioptimization of the determination of polychlorinated biphenyl congeners in human milk by headspace solid phase microextraction coupled to gas chromatography with electron capture detection Original Research Article
608
Neuro-genetic non-invasive temperature estimation: Intensity and spatial prediction
609
Neuro-genetic PID autotuning: time invariant case Original Research Article
610
Neuro-genetic prediction of software development effort
611
Neurogenetics study was unethical, says NNI report
612
Neurogenic and non-neurogenic mechanisms in response of rat distal colon muscle to dextran sulphate sodium treatment
613
Neurogenic cardiac damage and sudden death
614
Neurogenic cells in human amniotic fluid
615
Neurogenic claudication by epidural lipomatosis: a case report and review of literature
616
Neurogenic cluttering
617
Neurogenic Communication Disorders: a Functional Approach, Edited by L.E. Worrall, C.M. Frattali. New York/Stuttgart, Thieme 2000. TNY ISBN 0-96577-868-X; GTV ISBN 3-13-124471-2
618
Neurogenic essential hypertension revisited: the case for increased clinical and research attention
619
Neurogenic factors in hypertension caused by renal injury
620
Neurogenic failures of the external urethral sphincter closure and relaxation; a videourodynamic study
621
Neurogenic induction of human dental pulp derived stem cells by hanging drop technique, basic fibroblast growth factor, and SHH factors
622
Neurogenic myocardial dysfunction related to pulsatile compression of medulla by aneurysm
623
Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis
624
Neurogenic ST depression in stroke
625
Neurogenic stunned myocardium in a patient with metastatic brain tumors
626
Neurogenic stuttering versus developmental stuttering: An observer judgement study
627
Neurogenic tumors of the mediastinum originated from the vagus nerve
628
Neurogenic Vocal Fold Motion Impairment After Routine Intubation for Tonsillectomy in a Pediatric Patient
629
Neurogenin Promotes Neurogenesis and Inhibits Glial Differentiation by Independent Mechanisms
630
Neurogenins in brain development and disease: An overview
631
Neurogenomics—a capital investment?
632
Neuroglial response after induction of experimental allergic encephalomyelitis in susceptible and resistant rat strains
633
Neuroglial-mediated immunoinflammatory responses in Alzheimerʹs disease: Complement activation and therapeutic approaches
634
Neuroglobin and Prion Cellular Localization: Investigation of a Potential Interaction
635
Neuroglobin as a Neuroprotective in Neonates with Hypoxic Ischemic Encephalopathy
636
Neuroglobin might protect brain cells during stroke
637
Neuroglobin protects PC12 cells against β-amyloid-induced cell injury
638
Neuroglycopenic and other symptoms in patients with insulinomas
639
Neurographic assessment of lesions of single proper digital nerves
640
Neurohealth Properties of Hericium erinaceus Mycelia Enriched with Erinacines
641
Neurohormonal activation and diagnostic value of cardiac peptides in patients with suspected mild heart failure
642
Neurohormonal activation and left ventricular ejection fraction in patients with suspected myocardial ischemia
643
Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: Relation to hemodynamic variables and endothelin levels
644
Neurohormonal activation in patients with systemic sclerosis-related pulmonary arterial hypertension
645
Neurohormonal activation in severe heart failure: Relations to patient death and the effect of treatment with flosequinan
646
Neurohormonal activation rapidly decreases after intravenous therapy withdiuretics and vasodilators for class IV heart failure
647
Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension, , ,
648
Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure
649
Neurohormonal and dietary influences on hippocampal-dependent inhibitory controls of food intake
650
Neurohormonal blockade in chronic heart failure: How much is enough? can there be too much?
651
Neurohormonal changes in medical students during academic stress
652
Neurohormonal factors in the development of catabolic/anabolic imbalance and cachexia
653
Neurohormonal Inhibition in Heart Failure: Insights from Recent Clinical Trials
654
Neurohormonal modulation in cardiovascular disease
655
Neurohormonal perturbations in fibromyalgia
656
Neurohormonal prediction of mortality following admission for decompensated heart failure
657
Neurohormonal Response to Head-Up Tilt and Its Role in Vasovagal Syncope
658
Neurohormonal responses during positive pressure mechanical ventilation
659
Neurohormonal, Structural, and Functional Recovery Pattern After Premature Ventricular Complex Ablation Is Independent of Structural Heart Disease Status in Patients With Depressed Left Ventricular Ejection Fraction: A Prospective Multicenter Study
660
Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine
661
Neurohormones as markers of right- and left-sided cardiac dimensions and function in patients with untreated chronic heart failure
662
Neurohumoral activations in congestive heart failure: Correlations with cardiac function, heart rate variability, and baroreceptor sensitivity,
663
Neurohumoral Cardiovascular Responses to Alcohol and Their Modulation by Peroral Fluid
664
Neurohumoral characteristics of older hypertensive patients with abnormal nocturnal blood pressure dipping
665
Neurohumoral measurements as indicators of bong-terns prognosis after acute myocardial infarction
666
Neurohumoral regulation in ischemia-induced heart failure: Role of the forebrain
667
Neurohumoral variability in left ventricular dysfunction
668
Neuro-hypnotism: Prospects for hypnosis and neuroscience
669
Neurohypophyseal peptides in aging and Alzheimer’s disease
670
Neuro-imagerie et états de stress post-traumatiques
671
Neuroimages of disseminated neurotuberculosis: Report of one case
672
Neuroimaging – Chance effects and unintended consequences
673
Neuroimaging and Attention-Deficit/Hyperactivity Disorder in the 21st Century: What to Consider and How to Proceed
674
Neuroimaging and early Alzheimerʹs disease
675
Neuroimaging and neuroenergetics: Brain activations as information-driven reorganization of energy flows
676
Neuroimaging correlates of anxiety after pediatric traumatic brain injury
677
Neuroimaging Evaluation for First Attack of Unprovoked Nonfebrile Seizure in Pediatrics: When to Order?
678
NEUROIMAGING FINDING OF ORGANIC ACADEMIA IN CHILDREN
679
Neuroimaging Findings in First Unprovoked Seizures: A Multicentric Study in Tehran
680
Neuroimaging findings in frontotemporal lobar degeneration spectrum of disorders
681
Neuroimaging in bipolar disorder: what have we learned?
682
Neuroimaging in borderline personality disorder
683
Neuroimaging in Cerebral Palsy – Report from North India
684
NEUROIMAGING IN CHILDREN WITH FIRST AFEBRILE SEIZURES: TO ORDER OR NOT TO ORDER?
685
Neuroimaging in chronic fatigue syndrome
686
Neuroimaging in communication sciences and disorders: An introduction
687
Neuroimaging in Iran: A Review
688
Neuroimaging in ophthalmology
689
Neuroimaging in Outpatients with Tension Type Headache
690
Neuroimaging in Pediatric Optic Neuritis: A Narrative Review
691
Neuroimaging in psychiatry: an update
692
Neuroimaging in sexual offenses and paraphilia: A call to harmonize current clinical and imaging assessments in sexual offenses and paraphilia
693
Neuroimaging of emotion and personality: Scientific evidence and ethical considerations
694
Neuroimaging of Higher Cognitive Function
695
Neuroimaging of interval timing
696
Neuroimaging of Performance Monitoring: Error Detection and Beyond
697
Neuroimaging on delayed postanoxic encephalopathy with lesions localized in basal ganglia
698
NEUROIMAGING OUTCOMES IN CLINICAL TRIALS IN ALZHEIMER’S DISEASE
699
Neuroimaging research and the neurobiology of obsessive–compulsive disorder: where do we go from here?
700
Neuroimaging resolution of the altered state hypothesis
701
Neuroimaging studies in Rett syndrome
702
Neuroimaging studies of delirium: A systematic review
703
Neuroimaging studies of mood disorder effects on the brain
704
Neuroimaging studies of mood disorders
705
Neuroimaging studies of obsessive–compulsive disorder in adults and children
706
Neuroimaging studies of practice-related change: fMRI and meta-analytic evidence of a domain-general control network for learning
707
Neuroimaging studies of psychological interventions for mood and anxiety disorders: Empirical and methodological review
708
Neuroimaging studies of speech: An overview of techniques and methodological approaches
709
Neuroimaging studies of the cerebellum: language, learning and memory
710
Neuroimaging study of myotonic dystrophy. I. Magnetic resonance imaging of the brain
711
Neuroimaging study of myotonic dystrophy. II. MRI measurements of the brain
712
Neuroimaging techniques offer new perspectives on callosal transfer and interhemispheric communication
713
Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy
714
Neuroimaging, Uncertainty, and the Problem of Dispositions
715
Neuroimaging, Volume I Basic Science; Volume II Clinical Applications, , : edited by Erin D. Bigler, New York: Plenum Press, 1996, Volume I, 342 pp. and Volume II, 365 pp.
716
Neuroimaging. Cambridge medical reviews — neurobiology and psychiatry, vol. 3
717
NEURO-IMAGING: STRUCTURAL AND FUNCTIONAL IMAGING
718
Neuroimaging-based approaches in the brain–computer interface
719
Neuroimaging-based markers of bipolar disorder: Evidence from two meta-analyses
720
Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder
721
Neuroimmune appendicitis Original Research Article
722
Neuroimmune appendicitis, peptides, and schizophrenia
723
Neuro-immune connection in spread of prions in the body?
724
Neuro-immune connections: evidence for a neuro-immunological synapse
725
Neuro-immune interactions in the lung
726
Neuroimmune networks and communication pathways: the importance of location
727
Neuroimmune response and sleep studies after whole body irradiation with high-LET particles Original Research Article
728
Neuroimmunoendocrine circuitry of the ‘brain-skin connection’
729
Neuroimmunology of the paraneoplastic neurological degenerations
730
Neuroimmunotoxic Effects of Occupational Exposure to Lead and Mercury
731
Neuroinfections: celebrating the past, discussing the present
732
Neuroinflammation and Alzheimer’s disease: critical roles for cytokine/Aβ-induced glial activation, NF-κB, and apolipoprotein E
733
Neuroinflammation and anti-inflammatory therapy for Alzheimer’s disease
734
Neuroinflammation in Autism Spectrum Disorders: the Role of High Mobility Group Box 1 Protein
735
Neuroinflammation in multiple sclerosis: Evidence for autoimmune dysregulation, not simple autoimmune reaction
736
Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimerʹs Disease
737
Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development
738
Neuroinflammatory State of Multiple Sclerosis and Strategies for Biotherapeutics Development
739
Neuroinformatics Research for Vision Science: NRV project
740
Neuroinformatics: A new tool for studying the brain
741
Neurointensive care unit system for continuous electrophysiological monitoring with remote web-based review
742
Neuroinvasion by Chandipura virus
743
Neurokinin B peptide serum levels are higher in normotensive pregnant women than in preeclamptic pregnant women
744
Neurokinin-1 receptor expression in the mature dental pulp of rats
745
Neurokinin-1 receptors in the cerebrovascular vasoactive intestinal polypeptide-containing nerves in the rat
746
Neurolathyrism in Ethiopia: assessment and comparison of knowledge and attitude of health workers and rural inhabitants
747
Neurolaw and consciousness detection
748
Neurolaw: A brief introduction.
749
Neuroleptic binding to sigma receptors: Possible involvement in neuroleptic-induced acute dystonia
750
Neuroleptic discontinuation in clinical and research settings: scientific issues and ethical dilemmas
751
Neuroleptic drug exposure and treatment of parkinsonism in the elderly: A case-control study
752
Neuroleptic Malignant Syndrome
753
Neuroleptic Malignant Syndrome (NMS) on Clozapine with aPotential Atypical Interaction with Paliperidone
754
Neuroleptic malignant syndrome after venlafaxine
755
Neuroleptic malignant syndrome after venlafaxine
756
Neuroleptic malignant syndrome after venlafaxine Original Research Article
757
Neuroleptic malignant syndrome and catatonia: One entity or two?
758
Neuroleptic malignant syndrome and catatonia: One entity or two?
759
Neuroleptic malignant syndrome associated with nortriptyline
760
Neuroleptic malignant syndrome in a burn patient
761
Neuroleptic malignant syndrome in the burns patient?
762
Neuroleptic Malignant Syndrome Revisited in the Perspective of Pakistan
763
Neuroleptic malignant syndrome with gangliosidosis type II
764
Neuroleptic malignant-like syndrome in an elderly patient caused by abrupt withdrawal of tolcapone, a catechol-O-methyl transferase inhibitor
765
Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimerʹs disease
766
Neuroleptic sensitivity to risperidone in Lewy body dementia
767
Neuroleptic treatment and caudate plasticity
768
Neuroleptic-induced akathisia and early onset tardive dyskinesia in affective disorder due to Cushingʹs syndrome
769
Neuroleptic-induced tardive dyskinesia among Arab psychotic patients
770
Neuroleptics in progressive structural brain abnormalities in psychiatric illness
771
Neuroleptiques et sujet âgé
772
Neuro-levelset system based segmentation in dynamic susceptibility contrast enhanced and diffusion weighted magnetic resonance images
773
Neuroligin Expressed in Nonneuronal Cells Triggers Presynaptic Development in Contacting Axons
774
Neuro-linguistic approach to pattern recognition
775
Neurolinguistic aspects of attrition
776
Neurolinguistic Programming (NLP) and Transformational Leadership: A Conceptual Model for Malaysian Women Leader and Representative
777
NEUROLINGUISTIC PROGRAMMING (NLP): ITS OVERVIEW AND REVIEW IN THE LENSES OF PHILOSOPHY AND PEDAGOGY
778
Neurolinguistics. An Introduction to Spoken Language Processing and its Disorders, John Ingram. Cambridge University Press, Cambridge (Cambridge Textbooks in Linguistics) (2007)
779
Neurologic and developmental disability after extremely preterm birth
780
Neurologic and otologic findings in Fisherʹs syndrome
781
Neurologic complications after graft replacement of the entire thoracoabdominal aorta
782
Neurologic complications after total shoulder arthroplasty
783
Neurologic complications including paralysis after a medication error involving implanted intrathecal catheters
784
Neurologic complications of coronary artery bypass grafting: Diffuse or focal ischemia?
785
Neurologic Complications of Methanol Poisoning: A Clinicoepidemiological Report from Poisoning Treatment Centers in Tehran, Iran
786
Neurologic complications of surgery for anterior shoulder instability
787
Neurologic complications of the Novacor left ventricular assist device
788
Neurologic disease and vitamin B12 deficiency
789
Neurologic Diseases Associated with Use of Plant Components with Toxic Potential
790
Neurologic drug-psychotropic drug update
791
Neurologic events after coronary bypass grafting: Further observations with warm cardioplegia
792
Neurologic exam
793
Neurologic Examination Abnormalities in Children with Bipolar Disorder or Attention-Deficit/Hyperactivity Disorder
794
Neurologic feature of horizontal gaze paly and progreive colioi with mutation in ROBO3
795
Neurologic infections in a Nigerian university teaching hospital
796
Neurologic injury in cardiac surgical patients with a history of stroke
797
NEUROLOGIC MANIFESTATION OF ORGANIC ACADEMIA
798
Neurologic manifestations and treatment of Henoch–Schönlein purpura
799
Neurologic manifestations in patients with COVID-19: A case report
800
Neurologic Manifestations in Staphylococcus aureus Endocarditis: A Review of 260 Bacteremic Cases in Nondrug Addicts
801
Neurologic Manifestations of Childhood Rheumatic Diseases
802
Neurologic Monitoring on Cardiopulmonary Bypass: What Are We Obligated to Do?
803
Neurologic outcome after thoracic and thoracoabdominal aortic aneurysm repair
804
Neurologic outcome in octogenarians after aortic arch repair with hypothermic circulatory arrest
805
Neurologic outcome in patients with MRI pattern of damage typical for neonatal hypoglycemia
806
Neurologic Presentations of COVID-19: A Case Series
807
Neurologic Preservation by Na+-H+ Exchange Inhibition Prior to 90 Minutes of Hypothermic Circulatory Arrest
808
Neurologic Sequelae Associated With Deep Hypothermic Circulatory Arrest
809
Neurologic sequelae of deep hypothermic circulatory arrest in cardiac transplant infants
810
Neurologic signs and mobility limitations: a neglected link in the elderly
811
Neurologic soft signs and low birthweight: their association and neuropsychiatric implications
812
Neurological Abnormalities in Schizophrenic Twins
813
Neurological adverse event after administration of the hepatitis A vaccine
814
NEUROLOGICAL AND NEUROPSYCHIATRIC SPECTRUM OF WILSON S DISEASE IN LOCAL POPULATION
815
Neurological and neuropsychological characteristics of occipital, occipito-temporal and occipito-parietal infarction
816
Neurological and neuropsychological signs in obsessive compulsive disorder: interaction with behavioural treatment
817
NEUROLOGICAL AND OTHER MANIFESTATIONS OF WILSON DISEASE; 1998-2005
818
Neurological and psychological sequelae in transplant recipients after bridging with the bioartificial liver
819
Neurological and Vascular Manifestations of Ethylmalonic Encephalopathy
820
Neurological artform
821
Neurological aspects of hair growth
822
Neurological aspects of multiple myeloma and related disorders
823
Neurological aspects of spinal-cord repair: promises and challenges
824
Neurological aspects of the Angelman syndrome
825
Neurological bases for balance–anxiety links
826
Neurological bases of behavioral development in infancy
827
Neurological basis of skill learning
828
Neurological cases for experts only!
829
Neurological comorbidity affects prognosis in left ventricular hypertrabeculation/noncompaction
830
Neurological Complication of Infective Endocarditis Misdiagnosing with Multiple Sclerosis: A Case Report
831
Neurological complications and Japanese encephalitis vaccination
832
Neurological Complications Following Percutaneous Coronary Interventions (A Report from the 2000–2001 New York State Angioplasty Registry)
833
Neurological complications in heparin-induced thrombocytopenia
834
Neurological complications in renal failure: a review
835
Neurological complications in β-thalassemia
836
Neurological Complications of Corona Virus: A Mini-Review
837
Neurological complications of HIV infection
838
Neurological complications of HIV infection
839
Neurological Compromise Associated With COVID-19 Is Broader Than Anticipated Comment on “COVID-19 Pandemic and Neurological Disease: A Critical Review of the Existing Literature”
840
Neurological Crises after Discontinuation of Nitisinone (NTBC) Treatment in 3 Cases of Tyrosinemia
841
Neurological deficit as the first manifestation of vesical transitional cell carcinoma
842
neurological deficit following combined spinal-Epidural Anesthesia for knee arthroplasty
843
Neurological Disorders and Oxidative Toxic Stress: A Role of Metal Nanoparticles
844
Neurological disorders and the structure of human consciousness
845
Neurological disorders caused by inherited ion-channel mutations
846
Neurological Disorders due to Recurrent Hypoglycemia
847
Neurological disturbances due to filgrastim
848
Neurological Dysfunction in Elderly Patients Undergoing Coronary Artery Bypass Operation
849
Neurological effects of high-dose idebenone in patients with Friedreichʹs ataxia: a randomised, placebo-controlled trial
850
Neurological efficacy of stavudine, zidovudine, and lamivudine
851
Neurological efficacy of stavudine, zidovudine, and lamivudine
852
Neurological evaluation and intelligence testing in the child with operated congenital heart disease
853
Neurological Examination and Hearing Assessment of Premature Infants with Gestational Age of Less Than 32 Weeks at Follow-up
854
Neurological examination findings to predict limitations in mobility and falls in older persons without a history of neurological disease
855
Neurological finding of Mitochondrial Syndromes (MERRF and MELAS)
856
Neurological findings and outcome in adult cerebral malaria
857
Neurological Functions of CEO Investment based on Varimax Analysis and Rotated Matrix in Q Typology
858
Neurological gait disorders in elderly people: clinical approach and classification
859
NEUROLOGICAL IMPROVEMENT AFTER CERVICAL TRACTION IN PATIENTS WITH CERVICAL SPINE INJURY
860
Neurological infection
861
Neurological infection in The Lancet Neurology
862
Neurological infections: clinical advances and emerging threats
863
Neurological infections: clinical advances, global threats
864
Neurological Involvement of Patients with COVID-19: Proposed Neuroinvasive Mechanisms and Management
865
Neurological manifestation of coeliac disease with particular emphasis on gluten ataxia and immunological injury: a review article
866
Neurological Manifestation of COVID-19: A Literature Review
867
Neurological Manifestations and Risk Factors of HTLV-1 Infection in the Middle East Region and Iran: A Comprehensive Review of 137 Articles of the Last 23 Years
868
Neurological Manifestations and their Correlated Factors in COVID-19 Patients; a Cross-Sectional Study
869
Neurological Manifestations as Presenting Feature of Osteopetrosis in Children; A Review of 11 Cases
870
Neurological Manifestations in Critically Ill COVID-19 Patients
871
Neurological manifestations in patients with antiphospholipid syndrome.
872
NEUROLOGICAL MANIFESTATIONS OF ALLGROVE SYNDROME
873
Neurological Manifestations of an Old Disease: A Case Report
874
Neurological manifestations of Behçet’s disease
875
Neurological Manifestations of Celiac Disease
876
Neurological manifestations of dengue infection Original Research Article
877
Neurological manifestations of Ehlers-Danlos syndrome(s): A review.
878
Neurological manifestations of Hansenʹs disease and their management
879
Neurological Manifestations of Hospitalized COVID-19-Infected Patients: A Single-Center Cohort Study
880
Neurological manifestations of knockout mice with β-galactosidase deficiency
881
Neurological Manifestations of Patients Hospitalized with Coronavirus Disease 2019 in Babol, Iran
882
Neurological Manifestations of Renal Diseases in Children in Qazvin/ Iran
883
NEUROLOGICAL MANIFESTATIONS OF WILSONʹS DISEASE
884
Neurological manifestations, diagnosis, and treatment of celiac disease: A comprehensive review
885
Neurological Measurement of Human Trust in Automation Using Electroencephalogram
886
Neurological mechanisms of green tea polyphenols in Alzheimerʹs and Parkinsonʹs diseases
887
Neurological melioidosis
888
Neurological Monitoring and Off-Pump Surgery in a Very High-Risk Stroke Patient
889
Neurological outcome and S100 after coronary artery bypass grafting and abdominal aortic surgery
890
Neurological outcome following delayed fixation of unstable thoracolumbar spinal injuries with short segment posterior fixation
891
Neurological outcome of normothermic versus hypothermic cardiopulmonary bypass in simple congenital heart diseases
892
Neurological outcomes in coronary surgery: independent effect of avoiding cardiopulmonary bypass
893
Neurological presentation of Griscelli syndrome: Obstructive hydrocephalus without haematological abnormalities or organomegaly
894
Neurological presentation of three patients with 22q11 deletion (CATCH 22 syndrome)
895
Neurological presentations of nutritional vitamin B12 deficiency in 42 breastfed infants in Southeast Turkey
896
Neurological prognosis correlated with variations over time in the number of subependymal nodules in tuberous sclerosis
897
Neurological recovery in 80 cases of rapid stereotactic evacuation and local fibrinolysis in spontaneous hematomas of putamen and thalamus
898
Neurological Rehabilitation of Stroke Patients by Means of a Robotically Assisted Brain Controlled Interface
899
Neurological sequelae following a high voltage electrical burn
900
Neurological sequelae in children born after in-vitro fertilisation: a population-based study
901
Neurological sequelae in in-vitro fertilisation babies
902
Neurological sequelae in in-vitro fertilisation babies
903
Neurological sequelae in in-vitro fertilisation babies
904
Neurological sequelae in in-vitro fertilisation babies
905
Neurological sequelae of cerebral malaria
906
Neurological sequelae of cerebral malaria
907
Neurological Sequels and Their Causes in Patients Hospitalized in the Toxicology Intensive Care Unit of Bahraloo Hospital, Tehran, Iran
908
Neurological soft signs and response to risperidone in chronic schizophrenia
909
Neurological soft signs in bipolar I disorder patients
910
Neurological soft signs in schizophrenia: Are they related to negative or positive symptoms, neuropsychological performance, and violence?
911
Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia
912
Neurological Soft Signs: A Further Step in the Diagnosis of Bipolar-I Disorder
913
Neurological Soft Signs: A Further Step in the Diagnosis of Bipolar-I Disorder?
914
Neurological Study of Radial Nerve Conduction During Endoscopic Radial Artery Harvesting:An Intra‐Operative Evaluation
915
Neurological Symptom in a Case of Adrenal Insufficiency
916
Neurological Symptoms as the First Presentation of Transitional Cell Carcinoma of Renal Pelvis
917
Neurological Wilson Disease in children: a three years experience from Multan
918
Neurologists are not immune
919
Neurologists determine the effect of migraine on quality of life
920
Neurologists give better stroke care
921
Neurologists say Florida woman is very unlikely to recover
922
Neurology 2.0
923
Neurology elective at The Royal London Hospital
924
Neurology in sub-Saharan Africa—WHO cares?
925
Neurology of paediatric infectious diseases and immunodeficiency
926
Neurology of Touretteʹs syndrome (TS) TS as a developmental dopamine disorder: a hypothesis
927
Neurology of widely embedded free will
928
Neurology on the global health agenda
929
Neurology residency training in Europe: an Italian perspective
930
Neurology starters: simple to sublime
931
Neurology training around the world
932
Neurolymphomatosis as a single sign of tumor recurrence in a patient with diffuse large B-cell lymphoma of the testis
933
Neurolymphomatosis in Recrudescent Diffuse Large B-cell Lymphoma
934
Neurolymphomatosis of brachial plexus: A rare clinical presentation and the role of 18F-FDG PET/CT
935
Neuromagnetic activity in alpha and beta bands reflect learning-induced increases in coordinative stability
936
Neuromagnetic alpha suppression during an auditory Sternberg task: Evidence for a serial, self-terminating search of short-term memory
937
Neuromagnetic correlates of intra- and extra-dimensional set-shifting
938
Neuromagnetic effects on Anomalous Cognitive Experiences: A Critical Appraisal of the Evidence for Induced Sensed-presence and Haunt-type Experiences
939
Neuromagnetic imaging of cortical oscillations accompanying tactile stimulation
940
Neuromagnetic responses to vowels vs. tones reveal hemispheric lateralization
941
Neuromagnetic source localization of auditory evoked fields and intracerebral evoked potentials: a comparison of data in the same patients
942
Neuromarketing: beyond branding
943
Neuromarketing: Where marketing and neuroscience meet
944
Neuromedin B receptor antagonist suppresses tumor angiogenesis and tumor growth in vitro and in vivo
945
Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway
946
Neuromelanins in various regions of human brain are associated with native and oxidized isoprenoid lipids
947
Neurometabolic Diagnosis in Children who referred as Neurodevelopmental Delay (A Practical Criteria, in Iranian Pediatric Patients)
948
Neurometabolic Registry Site in Iran
949
Neuromodelling
950
Neuro-models for discharge air temperature system
951
Neuromodulation of parietal and motor activity affects motor planning and execution
952
Neuromodulation therapy does not influence blood flow distribution or left-ventricular dynamics during acute myocardial ischemia
953
Neuromodulation: acetylcholine and memory consolidation
954
Neuromodulation: An Overview
955
Neuromodulations of the Intractable Neurologic Symptoms
956
Neuromodulatory control of hippocampal function: towards a model of Alzheimer’s disease
957
Neuromodulatory role of Bacopa monnieri on oxidative stress induced by postnatal exposure to decabromodiphenyl ether (PBDE -209) in neonate and young female mice
958
Neuromodulatory unpaired median neurons in the New Zealand tree weta, Hemideina femorata
959
Neuromolecularware and its application to pattern recognition
960
Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation
961
Neuromonitoring for awareness during surgery
962
Neuromonitoring of the external branch of the superior laryngeal nerve during thyroid surgery
963
Neuro-monte carlo solution of electrostatic problems
964
Neuromorbidity in preterm twins in relation to chorionicity and discordant birth weight
965
Neuromorphic implementation of orientation hypercolumns
966
Neuromorphic Synapses for Artificial Dendrites
967
Neuromotor control in stuttering: Speech, orofacial nonspeech, and finger movements
968
Neuromotor Issues in Human Performance: Introduction
969
Neuromotor Issues in the Learning and Control of Golf Skill
970
Neuro-mucormycosis: Lessons from COVID-19-associated cases
971
Neuromuscular Adjustments of the Quadriceps Muscle After Eccentric Resistance and Concentric Resistance Training
972
Neuromuscular and balance responses to flywheel inertial versus weight training in older persons
973
Neuromuscular and Blood Lactate Response After a Motocross Training Session in Amateur Riders
974
Neuromuscular and Metabolic Responses to Three Different Resistance Exercise Methods
975
Neuromuscular and psychomotor abnormalities in patients with schizophrenia and their first-degree relatives
976
Neuromuscular and spatial constraints on bimanual hand-held pendulum oscillations: Dissociation or combination?
977
Neuromuscular Blockade After Ingestion of Tree Tobacco (Nicotiana glauca), ,
978
Neuromuscular blockade as part of an anaesthetic protocol for cataract surgery in an alpaca
979
Neuromuscular Blockade, Bariatric Surgeon Satisfaction, and Quality of Patient Recovery
980
Neuromuscular Blocking Agent Use in Acute Respiratory Distress Syndrome: Which Variable is Important?
981
NEUROMUSCULAR BLOCKING AGENTS IN THE INTENSIVE CARE UNITS
982
Neuromuscular changes in a rat model of colitis
983
Neuromuscular Characteristics of Endurance- and Power-Trained Athletes
984
Neuromuscular consequences of prolonged hunger strike: an electrophysiological study
985
Neuromuscular Control and Coordination During Cycling
986
Neuromuscular control model of the arm including feedback and feedforward components
987
Neuromuscular disease laboratory
988
Neuromuscular diseases: therapeutic advances
989
Neuromuscular disorder in response to anterior cruciate ligament creep
990
Neuromuscular disorders in critical illness
991
Neuromuscular disorders: molecular and therapeutic insights
992
Neuromuscular disorders: orphan diseases deserve attention
993
Neuromuscular disorders: therapeutic advances
994
Neuromuscular dysfunction associated with delayed weaning from mechanical ventilation in patients with respiratory failure
995
NEUROMUSCULAR EFFECTS OF CISATRACURIUM IN MORBIDLY OBESE PATIENTS
996
Neuromuscular Electric Stimulation Versus Traditional Treatment on Harris Hip Score in Cases of Avascular Necrosis of Femoral Head After Kidney Transplantation
997
NEUROMUSCULAR ELECTRICAL STIMULATION OF MEDIUM and LOW FREQUENCY ON THE QUADRICEPS FEMORIS
998
Neuromuscular Electrical Stimulation of the Cricothyroid Muscle in Patients With Suspected Superior Laryngeal Nerve Weakness
999
Neuromuscular excitability properties in myotonic dystrophy type 1
1000
Neuromuscular function and bone density as independent predictors of fracture in older women: A 10-year longitudinal study